Eaton Vance Worldwide Health Sciences Fund

Scorecard
2 / 5 Stars
Lipper
3 3 5 1 1
Zacks Investment Research
2 (Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
A (Buy)

Fund Holdings

Asset Allocation

% Long % Short % Net
Cash 0.94 0.15 0.79
Stocks 71.13 0.0 71.13
Bonds 0.0 0.0 0.0
Other 0.23 0.0 0.23
Foreign Bonds 0.0 0.0 0.0
Foreign Stocks 27.85 0.0 27.85
Convertible 0.0 0.0 0.0
Preferred 0.0 0.0 0.0

Updated 12.31.2013

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 12.31.2013

Ticker YTD Return % % Net Assets
Roche Holding AG RHHVF 4.05 7.01
Gilead Sciences Inc GILD 8.46 5.46
HCA Holdings Inc HCA 8.34 4.26
Regeneron Pharmaceuticals, Inc. REGN 23.35 4.09
Incyte Corp Ltd INCY 25.91 4.0
Mylan Inc MYL 27.93 3.67
Amgen Inc AMGN 8.96 3.53
ONO Pharmaceutical Co., Ltd. OPHLF 19.52 3.44
Bristol-Myers Squibb Company BMY 0.64 3.31
Biogen Idec Inc BIIB 21.04 3.3